OrganOx is a medical device company dedicated to enhancing organ transplantation outcomes through advanced technology. Established in 2008 as a spinout from the University of Oxford, OrganOx has developed the OrganOx metra® normothermic machine perfusion system, which has been instrumental in facilitating over 5,000 liver transplant procedures worldwide. This innovative device optimizes the utilization of donated organs by allowing for their assessment and extending preservation times, ultimately aiming to save lives. The company's core values emphasize innovation, integrity, teamwork, and respect, all of which support its mission to improve health outcomes globally. OrganOx offers a collaborative environment that encourages professional development and values contributions from diverse talent within the organization.